4
Changes in Ownership
Structure Therapeutics Inc. Filed Acc 0001415889-24-023794
Chief Development Officer acquired 67,290 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hall Ashley Chief Development Officer | 2024-09-18 | Grant or award | +67,290 | 67,290 | D | ||
| Derivatives | |||||||
| Hall Ashley Chief Development Officer | 2024-09-18 | Grant or award · Share option (right to buy) | +82,890 | 82,890 | D | ||
Loading xslF345X05/form4-09202024_090932.xml…